Literature DB >> 35978175

Heart Failure with Preserved Ejection Fraction in Children.

Bibhuti Das1, Shriprasad Deshpande2, Jyothsna Akam-Venkata3, Divya Shakti3, William Moskowitz3, Steven E Lipshultz4.   

Abstract

Diastolic dysfunction (DD) refers to abnormalities in the mechanical function of the left ventricle (LV) during diastole. Severe LVDD can cause symptoms and the signs of heart failure (HF) in the setting of normal or near normal LV systolic function and is referred to as diastolic HF or HF with preserved ejection fraction (HFpEF). Pediatric cardiologists have long speculated HFpEF in children with congenital heart disease and cardiomyopathy. However, understanding the risk factors, clinical course, and validated biomarkers predictive of the outcome of HFpEF in children is challenging due to heterogeneous etiologies and overlapping pathophysiological mechanisms. The natural history of HFpEF varies depending upon the patient's age, sex, race, geographic location, nutritional status, biochemical risk factors, underlying heart disease, and genetic-environmental interaction, among other factors. Pediatric onset HFpEF is often not the same disease as in adults. Advances in the noninvasive evaluation of the LV diastolic function by strain, and strain rate analysis with speckle-tracking echocardiography, tissue Doppler imaging, and cardiac magnetic resonance imaging have increased our understanding of the HFpEF in children. This review addresses HFpEF in children and identifies knowledge gaps in the underlying etiologies, pathogenesis, diagnosis, and management, especially compared to adults with HFpEF.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Adolescents; Child; Diastolic heart failure; HFpEF: Heart failure with preserved ejection fraction; Pediatric

Year:  2022        PMID: 35978175     DOI: 10.1007/s00246-022-02960-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.838


  154 in total

1.  Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy.

Authors:  M Jacob Adams; Stuart R Lipsitz; Steven D Colan; Nancy J Tarbell; S Ted Treves; Lisa Diller; Nina Greenbaum; Peter Mauch; Steven E Lipshultz
Journal:  J Clin Oncol       Date:  2004-08-01       Impact factor: 44.544

2.  Heart failure in children: part I: history, etiology, and pathophysiology.

Authors:  Daphne T Hsu; Gail D Pearson
Journal:  Circ Heart Fail       Date:  2009-01       Impact factor: 8.790

3.  Increasing exercise in long-term survivors of pediatric cancer and their siblings: should treatment be a family affair?

Authors:  Rudolf Steiner
Journal:  Pediatr Blood Cancer       Date:  2013-01-17       Impact factor: 3.167

4.  Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.

Authors:  Steven E Lipshultz; Stuart R Lipsitz; Stephen E Sallan; Virginia M Dalton; Suzanne M Mone; Richard D Gelber; Steven D Colan
Journal:  J Clin Oncol       Date:  2005-04-20       Impact factor: 44.544

5.  Interpretation of left ventricular diastolic dysfunction in children with cardiomyopathy by echocardiography: problems and limitations.

Authors:  Andreea Dragulescu; Luc Mertens; Mark K Friedberg
Journal:  Circ Cardiovasc Imaging       Date:  2013-01-23       Impact factor: 7.792

6.  Congestive heart failure: echocardiographic insights.

Authors:  H H Echeverria; M S Bilsker; R J Myerburg; K M Kessler
Journal:  Am J Med       Date:  1983-11       Impact factor: 4.965

7.  Echocardiographic Detection of Increased Ventricular Diastolic Stiffness in Pediatric Heart Transplant Recipients: A Pilot Study.

Authors:  Shahryar M Chowdhury; Ryan J Butts; Anthony M Hlavacek; Carolyn L Taylor; Karen S Chessa; Varsha M Bandisode; Girish S Shirali; Arni Nutting; G Hamilton Baker
Journal:  J Am Soc Echocardiogr       Date:  2017-12-13       Impact factor: 5.251

8.  Heart failure with preserved ejection fraction in children: hormonal imbalance between aldosterone and brain natriuretic peptide.

Authors:  Satoshi Masutani; Hirofumi Saiki; Clara Kurishima; Hirotaka Ishido; Masanori Tamura; Hideaki Senzaki
Journal:  Circ J       Date:  2013-05-31       Impact factor: 2.993

9.  Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.

Authors:  S E Lipshultz; S D Colan; R D Gelber; A R Perez-Atayde; S E Sallan; S P Sanders
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

10.  Subtle cardiac dysfunction in lymphoma patients receiving low to moderate dose chemotherapy.

Authors:  Hsien-Yuan Chang; Chun-Hui Lee; Po-Lan Su; Sin-Syue Li; Ming-Yueh Chen; Ya-Ping Chen; Ya-Ting Hsu; Wei-Chuan Tsai; Ping-Yen Liu; Tsai-Yun Chen; Yen-Wen Liu
Journal:  Sci Rep       Date:  2021-03-29       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.